ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1866

Patient-reported Impact of Axial Spondyloarthritis on Working Life. Results from the Spanish Atlas 2017

Marco Garrido-Cumbrera1, Eduardo Collantes-Estévez2, Victoria Navarro-Compán3, Pedro Zarco4, Carlos Sastre5, Sergio Sanz-Gomez6, José Correa-Fernández7 and Jordi Gratacós8, 1Health & Territory Research (HTR), Universidad de Sevilla / Spanish Federation of Spondyloarthritis Associations, Sevilla, Spain, 2Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Córdoba, Spain, 3Hospital Universitario La Paz IdiPaz, Madrid, Pais Vasco, Spain, 4Novartis Farmacéutica Spain, Alcorcon, Madrid, Spain, 5Novartis Pharma AG, Basel, Switzerland, 6Health & Territory Research, Seville, Spain, 7Health & Territory Research (HTR), Universidad de Sevilla, Sevilla, Spain, 8University Hospital Parc Tauli Sabadell, Barcelona, Spain

Meeting: ACR Convergence 2020

Keywords: Patient reported outcomes, spondyloarthritis, work, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Axial spondyloarthritis (axSpA) impacts negatively on multiple dimensions of patient’s life, including their working life. The present study aims to evaluate working status, work-related issues and their associated factors in a Spanish sample of patients with axSpA.

Methods: The Atlas 2017 based its results on an extensive cross-sectional patient survey conducted in Spain (2016), validated by a multidisciplinary group of experts on spondyloarthritis. Participants were recruited through an on-line panel and patient organizations. Participants were classified as active (employed, unemployed between 15-64 years) and inactive (retirees, on sick leave, students and homemakers). Those employed were asked to report work-related issues due to axSpA (sick-leave, difficulty fulfilling work hours, missing work for doctors’ appointments, reducing working hours or taking days off) in the past 12 months. Diagnostic delay, disease activity (BASDAI), spinal stiffness (3-12), functional limitation (0-54) and psychological distress (General Health Questionnaire, GHQ-12 [0-12]) were compared between employed patients with or without work-related issues using a Mann-Whitney and Kruskal-Wallis test. Regression analysis was conducted to determine explicative disease outcome related factors (enter method for BASDAI, self-reported spinal stiffness, functional limitation and GHQ-12) over work-related issues.

Results: Data from 680 patients were collected: mean age was 47±11 years, 52.5% were female and 36.9% were university educated. Mean disease duration and diagnostic delay were 20.9±12.2 and 8.5±7.7 years, respectively, and mean BASDAI was 5.5±2.2. A total of 63.6% (n=415) were considered active population, of which 49.8% (n=325) were employed (Table 1). Of those employed, 54.3% reported a work-related issue, specifically 37.1% took sick leave, 44.1% had difficulties in fulfilling the working hours and 42.9% missed work due to doctor’s appointments (Table 2). Among all patients, 95.5% faced (or believed they would) difficulties finding a job due to axSpA. Experiencing work-related issues due to axSpA was significantly associated with higher disease activity, self-reported spinal stiffness, longer diagnostic delay, higher functional limitation and higher level of psychological distress (p< 0.001). However, the highest levels of disease burden were reported by unemployed participants (Table 3).

Conclusion: Results reveal a relevant impact of axSpA in patient working life. Approximately two out of three patients employed experienced work-related issues due to axSpA, being associated to worse disease outcomes and poorer psychological health. However, those who were unemployed faced a harsher situation reporting even poorer disease-related and psychological health outcomes. As psychological health appears impaired severely in axSpA patients regardless of their employment status it should be key for a holistic approach to patient care.

Table 1. Employment status of survey respondents

Table 2. Frequencies of work-related issues surveyed among employed respondents

Table 3. Differences between employees with/without work-related issues and between employed/unemployed participants in relation to sociodemographic characteristics and patient-reported outcomes


Disclosure: M. Garrido-Cumbrera, None; E. Collantes-Estévez, None; V. Navarro-Compán, Novartis Pharma, 1, 5, 8, AbbVie Inc., 5, 8, Eli Lilly and Company, 5, 8, Pfizer Inc., 5, UCB, 5, 8; P. Zarco, None; C. Sastre, Novartis, 3; S. Sanz-Gomez, None; J. Correa-Fernández, None; J. Gratacós, AbbVie Inc., 5, 8, Eli Lilly and Company, 5, 8, Pfizer Inc., 5, 8, MSD, 5, 8, UCB, 5, 8, Novartis, 5, 8, Janssen Pharmaceutical, 5, 8, Amgen, 5, 8, BMS, 2, 5, 8, Celgene, 2, 5, 8.

To cite this abstract in AMA style:

Garrido-Cumbrera M, Collantes-Estévez E, Navarro-Compán V, Zarco P, Sastre C, Sanz-Gomez S, Correa-Fernández J, Gratacós J. Patient-reported Impact of Axial Spondyloarthritis on Working Life. Results from the Spanish Atlas 2017 [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/patient-reported-impact-of-axial-spondyloarthritis-on-working-life-results-from-the-spanish-atlas-2017/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-impact-of-axial-spondyloarthritis-on-working-life-results-from-the-spanish-atlas-2017/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology